JPS6399042A - Benzene based compound - Google Patents
Benzene based compoundInfo
- Publication number
- JPS6399042A JPS6399042A JP62115590A JP11559087A JPS6399042A JP S6399042 A JPS6399042 A JP S6399042A JP 62115590 A JP62115590 A JP 62115590A JP 11559087 A JP11559087 A JP 11559087A JP S6399042 A JPS6399042 A JP S6399042A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- alkyl
- pyridyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title abstract description 45
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 title 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 16
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 13
- 125000003118 aryl group Chemical group 0.000 claims abstract description 12
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 10
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims abstract description 5
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract description 16
- 125000004925 dihydropyridyl group Chemical class N1(CC=CC=C1)* 0.000 abstract description 9
- 239000002904 solvent Substances 0.000 abstract description 7
- 125000005843 halogen group Chemical group 0.000 abstract description 4
- 150000001447 alkali salts Chemical class 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract description 2
- 229940093858 ethyl acetoacetate Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 34
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 16
- -1 5ee-butyl Chemical group 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 229940085304 dihydropyridine derivative selective calcium channel blockers with mainly vascular effects Drugs 0.000 description 5
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 239000005060 rubber Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- QXHDYMUPPXAMPQ-UHFFFAOYSA-N 2-(4-aminophenyl)ethanol Chemical compound NC1=CC=C(CCO)C=C1 QXHDYMUPPXAMPQ-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- PYWRQTCBUSSNKO-UHFFFAOYSA-N 2-[4-(dibenzylamino)phenyl]ethanol Chemical compound C1=CC(CCO)=CC=C1N(CC=1C=CC=CC=1)CC1=CC=CC=C1 PYWRQTCBUSSNKO-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YDTXVOVKGSXZBI-UHFFFAOYSA-N 1-(4-aminophenyl)propan-1-ol Chemical compound CCC(O)C1=CC=C(N)C=C1 YDTXVOVKGSXZBI-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RCSDZDMUWBOOKI-UHFFFAOYSA-N 2-[4-(dibenzylamino)phenyl]ethyl 3-oxobutanoate Chemical compound C1=CC(CCOC(=O)CC(=O)C)=CC=C1N(CC=1C=CC=CC=1)CC1=CC=CC=C1 RCSDZDMUWBOOKI-UHFFFAOYSA-N 0.000 description 1
- CDTPAAZQBPSVGS-UHFFFAOYSA-N 2-[4-(dimethylamino)phenyl]ethanol Chemical compound CN(C)C1=CC=C(CCO)C=C1 CDTPAAZQBPSVGS-UHFFFAOYSA-N 0.000 description 1
- YMDZDFSUDFLGMX-UHFFFAOYSA-N 2-chloro-n-(2-chloroethyl)ethanamine;hydron;chloride Chemical compound [Cl-].ClCC[NH2+]CCCl YMDZDFSUDFLGMX-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000006226 butoxyethyl group Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- NWVNXDKZIQLBNM-UHFFFAOYSA-N diphenylmethylpiperazine Chemical compound C1CNCCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 NWVNXDKZIQLBNM-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006229 isopropoxyethyl group Chemical group [H]C([H])([H])C([H])(OC([H])([H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 125000006187 phenyl benzyl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000006225 propoxyethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、医薬品等として有用なジヒドロピリジン誘導
体を合成するための中間体等として有用な新規化合物に
関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a novel compound useful as an intermediate for synthesizing dihydropyridine derivatives useful as pharmaceuticals and the like.
〔従来技術・発明が解決しようとする問題点〕ジヒドロ
ピリジン誘導体としては、例えばニフェジピン、ニカル
ジピン等が知られている。これらの化合物は抗高血圧剤
、末梢および脳の血管拡張剤並びに冠動豚治療剤(狭心
症治療剤)として有用であることが知られている。[Prior Art/Problems to be Solved by the Invention] As dihydropyridine derivatives, for example, nifedipine, nicardipine, etc. are known. These compounds are known to be useful as antihypertensive agents, peripheral and cerebral vasodilators, and agents for treating coronary artery disease (angina pectoris).
本発明者らは新規ジヒドロピリジン誘導体、特に臓器、
m織選択性に優れしかも安全性の高い化合物を創製する
ために鋭意研究を続け、−g式:(式中、Rt 、R”
およびR3は同一または異なってアルキル、シクロアル
キルまたはアルコキシアルキルを、R4およびR8は同
一または異なって水素原子、ハロゲン、ニトロ、ハロゲ
ン化アルキル、アルキルスルホニル、ハロゲン化アルコ
キシ、アルキルスルフィニル、アルキル、シクロアルキ
ル、アルコキシ、シアノ、アルコキシカルボニルまたは
アルキルチオを(ただし、R4およびR5は同時に水素
原子ではない)、xはビニレンまたはアゾメチンで表わ
される基を、Aはアルキレンを、Bは−N (R’)!
または
に1
(R’およびR7はそれぞれ水素原子、アルキル、シク
ロアルキル、アラルキル、アリールまたはピリジルを、
Arはアリールまたはピリジルを、nは0〜2の整数を
それぞれ示す)で表わされる基を示す〕で表わされるジ
ヒドロピリジン誘導体(A)を創製し、当該化合物が臓
器、m織選択性に優れしかも安全性の高い化合物である
ことを見出すとともに、後記新規化合物(1)を原料化
合物として使用すればジヒドロピリジン誘導体(A)が
、効率的に、高収率で製造されることを見出し、さらに
研究を重ねて本発明を完成した。The present inventors have proposed novel dihydropyridine derivatives, especially for organs,
In order to create a compound that has excellent weave selectivity and is highly safe, we have continued our intensive research to create a compound with -g formula: (where Rt, R''
and R3 are the same or different and are alkyl, cycloalkyl, or alkoxyalkyl; R4 and R8 are the same or different and are hydrogen atom, halogen, nitro, halogenated alkyl, alkylsulfonyl, halogenated alkoxy, alkylsulfinyl, alkyl, cycloalkyl, Alkoxy, cyano, alkoxycarbonyl or alkylthio (however, R4 and R5 are not hydrogen atoms at the same time), x is a group represented by vinylene or azomethine, A is alkylene, B is -N (R')!
or 1 (R' and R7 each represent a hydrogen atom, alkyl, cycloalkyl, aralkyl, aryl or pyridyl,
Ar represents a group represented by aryl or pyridyl, and n represents an integer from 0 to 2, respectively. They discovered that dihydropyridine derivatives (A) can be produced efficiently and in high yields by using the new compound (1) described below as a raw material compound, and conducted further research. The present invention was completed.
本発明の目的はジヒドロピリジン誘導体(A)を効率的
に製造するために有用な新規化合物を提供するものであ
る。An object of the present invention is to provide a novel compound useful for efficiently producing dihydropyridine derivatives (A).
即ち、本発明は一般式(1)
%式%()
〔式中、Zは水酸基または一般式
R’−CO−CHt−COO−
(式中、R’はアルキル、シクロアルキルまたはアルコ
キシアルキルを示す)で表わされる基を、Aはアルキレ
ンを、Bは−N(R’)zまたは(R’およびR?はそ
れぞれ水素原子、アルキル、シクロアルキル、アラルキ
ル、アリールまたはピリジルを、Arはアリールまたは
ピリジルを、nは0〜2の整数をそれぞれ示す)で表わ
される基を示す〕で表わされる化合物に関する。That is, the present invention is based on the general formula (1) % formula % () [wherein Z is a hydroxyl group or the general formula R'-CO-CHt-COO- (wherein R' represents alkyl, cycloalkyl or alkoxyalkyl] ), A is alkylene, B is -N(R')z or (R' and R? are each hydrogen atom, alkyl, cycloalkyl, aralkyl, aryl or pyridyl, Ar is aryl or pyridyl) and n represents an integer of 0 to 2, respectively).
上記式中、R3で示されるアルキルは直鎖状、分岐状の
いずれでもよく、特に低級アルキル(Ct−*)が好ま
しく、例えばメチル、エチル、プロピル、イソプロピル
、ブチル、イソブチル、5ee−ブチル、t−ブチル、
ペンチル、イソペンチル、ネオペンチル、ヘキシルなど
が挙げられ、とりわけC1−4のものが好ましい。これ
らアルキルの末端にさらに低級シクロアルキル(C3−
4)を有してもよい(たとえばシクロプルピルメチル、
シクロブチルエチル、シクロペンチルメチル)、シクロ
アルキルふしては、低級(C2−4)シクロアルキルが
好ましく、たとえばシクロプルピル、シクロブチル、シ
クロペンチル、シクロヘキシルなどが挙げられる。また
、アルコキシアルキルとしては、炭素数の合計が3〜7
のものが好ましく、たとえばメトキシエチル、エトキシ
エチル、プロポキシエチル、イソプロポキシエチル、ブ
トキシエチル、メトキシプロピル、2−メトキシ−1−
メチルエチル、2−エトキシ−!−メチルエチルなどが
挙げられる。In the above formula, the alkyl represented by R3 may be linear or branched, and lower alkyl (Ct-*) is particularly preferable, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, 5ee-butyl, t -butyl,
Examples include pentyl, isopentyl, neopentyl, hexyl, etc., with C1-4 being particularly preferred. Lower cycloalkyl (C3-
4) (for example, cyclopropylmethyl,
cyclobutylethyl, cyclopentylmethyl), cycloalkyl, and lower (C2-4) cycloalkyl are preferred, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and the like. Furthermore, as alkoxyalkyl, the total number of carbon atoms is 3 to 7.
are preferred, such as methoxyethyl, ethoxyethyl, propoxyethyl, isopropoxyethyl, butoxyethyl, methoxypropyl, 2-methoxy-1-
Methyl ethyl, 2-ethoxy-! -Methyl ethyl and the like.
R6およびR?で示されるアルキル、シクロアルキルと
しては、前記R3で例示したものが挙げられる。アラル
キルとしては、ベンジル、α−フェニルエチル、β−フ
ェニルエチル、T−フェニルプロピルなどのフェニル−
C1−、アルキルが挙げられ、アリールとしてはフェニ
ル、ナフチルが挙げられ、これらの芳香環は任意の位置
に同一または異なる置換基を有していてもよい、これら
芳香環上の置換基の例としては、たとえば、ハロゲン原
子、ニトロ、ハロゲン化アルキル、アルキルスルホニル
、ハロゲン化アルコキシ、アルキルスルフィニル、アル
キル、シクロアルキル、アルコキシ、シアノ、アルコキ
シカルボニル、アルキルチオなどが挙げられる。ピリジ
ルとしては2−ピリジル、3−ピリジル、4−ピリジル
が挙げられ、これらは前記例示した置換基を有していて
もよい。R6 and R? Examples of the alkyl and cycloalkyl represented by include those exemplified for R3 above. Aralkyls include phenyl-benzyl, α-phenylethyl, β-phenylethyl, T-phenylpropyl, etc.
Examples of substituents on these aromatic rings include C1- and alkyl; examples of aryl include phenyl and naphthyl; these aromatic rings may have the same or different substituents at any position; Examples include halogen atom, nitro, halogenated alkyl, alkylsulfonyl, halogenated alkoxy, alkylsulfinyl, alkyl, cycloalkyl, alkoxy, cyano, alkoxycarbonyl, alkylthio, and the like. Examples of pyridyl include 2-pyridyl, 3-pyridyl, and 4-pyridyl, which may have the above-mentioned substituents.
Aで示されるアルキレンとしてはC2−1のちのが好ま
しく、直鎖状、分岐状のいずれでもよく、エチレン、ト
リメチレン、テトラメチレン、1゜2−ジメチルエチレ
ンなどが挙げられる。The alkylene represented by A is preferably after C2-1, and may be either linear or branched, and examples thereof include ethylene, trimethylene, tetramethylene, 1°2-dimethylethylene, and the like.
Arで示されるアリールおよびピリジルとしては、前記
R″およびR7で例示したものが挙げられ、同様の置換
基を有していてもよい。Aryl and pyridyl represented by Ar include those exemplified above for R'' and R7, and may have similar substituents.
本発明化合物(1)は一般的には以下のようにして製造
される。The compound (1) of the present invention is generally produced as follows.
+1) Zが水酸基、Bが−N (R’)tの化合物
(III ) (1−1)(式中、
AおよびR−は前述と同意義、Eはハロゲン原子を表わ
す)
化合物(I[[)と化合物(fV)を反応させて本発明
化合物(1−1)を得ることができる0本反応は、不活
性溶媒(例えば、N、N−ジメチルホルムアミド、ジメ
チルスルホキシド、ジグリム、エチレングリコールモノ
メチルエーテルなど)中、10〜120℃で1〜5時間
程度行われる。また、アルカリ塩(たとえば、炭酸カリ
ウムなど)の存在下に行うことが好ましい。+1) Compound (III) (1-1) in which Z is a hydroxyl group and B is -N (R')t (in the formula,
A and R- have the same meanings as above, E represents a halogen atom) The reaction in which the compound (1-1) of the present invention can be obtained by reacting the compound (I [[) with the compound (fV)) is as follows: The reaction is carried out in an inert solvent (eg, N,N-dimethylformamide, dimethyl sulfoxide, diglyme, ethylene glycol monomethyl ether, etc.) at 10 to 120°C for about 1 to 5 hours. Moreover, it is preferable to carry out in the presence of an alkali salt (for example, potassium carbonate, etc.).
1i*−(C1l) 、1−Ar
(式中、A%Ar%R?およびnは前述と同意義、El
およびE!はそれぞれハロゲン原子を表わす)まず、化
合物(III)と化合物(V)とを反応させて化合物(
Vr)を得る0本反応は、不活性溶媒(たとえば、n−
ブタノール、5ec−ブタノール、プロパツールなど)
中、加熱還流下で20〜30時間程度行われる。1i*-(C1l), 1-Ar (wherein A%Ar%R? and n have the same meanings as above, El
and E! each represents a halogen atom) First, compound (III) and compound (V) are reacted to form compound (
Vr) can be carried out using an inert solvent (e.g. n-
butanol, 5ec-butanol, propatool, etc.)
The process is carried out under heating under reflux for about 20 to 30 hours.
次いで、化合物(Vl)と化合物(■)とを反応させて
本発明化合物(1−2)を得ることができる。Next, the compound (Vl) and the compound (■) can be reacted to obtain the compound (1-2) of the present invention.
本反応の条件は製法(11と同様である。The conditions for this reaction are the same as in Production Method (11).
(3)ZがR” Co CHg Coo (D
化合物(1−1または l−2)
(%1N)〔式中、R”は低級アルキル基(通常、
C+−*)を示し、他の記号は全て前記と同意義〕
即ち、化合物(1−1または!−2)とジケテンまたは
化合物(■)とを反応させて製造される。化合物(■−
1または夏−2)とジケテンとの反応は、該混合物を無
溶媒かあるいは反応に不活性な溶媒中、通常約40〜約
130℃に加熱することにより行われるか、または反応
に不活性な溶媒(例、エチルエーテル、テトラヒドロフ
ラン、ジメトキシエタン等)中、たとえばバラジメチル
アミノピリジンなどの触媒の存在下約−20℃〜約40
℃で行うことができる。また、本発明化合物(1−3)
は、化合物(Llまたはl−2)と化合物(■)とを反
応させることによって製造できる0本反応は、たとえば
ナトリウムメトキシド、ナトリウムエトキシド、カリウ
ム【−ブトキシド、水素化ナトリウム、ナトリウムアミ
ド、金属ナトリウムなどの塩基の存在、下、不活性溶媒
中あるいは無溶媒下で約り0℃〜約100℃で行われる
。(3) Z is R” Co CHg Coo (D
Compound (1-1 or l-2)
(%1N) [In the formula, R'' is a lower alkyl group (usually
C+-*), and all other symbols have the same meanings as above.] That is, it is produced by reacting the compound (1-1 or !-2) with diketene or the compound (■). Compound (■-
The reaction between 1 or Natsu-2) and diketene is carried out by heating the mixture without a solvent or in a solvent inert to the reaction, usually at about 40 to about 130°C, or in a solvent inert to the reaction. in a solvent (e.g., ethyl ether, tetrahydrofuran, dimethoxyethane, etc.) in the presence of a catalyst such as, for example, varadimethylaminopyridine, from about -20°C to about 40°C.
Can be done at ℃. In addition, the compound of the present invention (1-3)
can be produced by reacting the compound (Ll or l-2) with the compound (■). For example, sodium methoxide, sodium ethoxide, potassium [-butoxide, sodium hydride, sodium amide, metal The reaction is carried out at about 0°C to about 100°C in the presence of a base such as sodium, in an inert solvent or without a solvent.
かくして製造される新規化合物(1)は、公知の分離精
製手段、たとえばtralll、抽出、クロマトグラフ
ィー、再沈澱、再結晶などを適宜用いることにより任意
の純度のものとして採取できる。The novel compound (1) thus produced can be collected in any purity by appropriately using known separation and purification means, such as trall, extraction, chromatography, reprecipitation, recrystallization, etc.
本発明の化合物(1)は、特に前記ジヒドロピリジン誘
導体(A)の製造用の原料として有用なものである。The compound (1) of the present invention is particularly useful as a raw material for producing the dihydropyridine derivative (A).
化合物(1)を使用するジヒドロピリジン1m体(A)
の製造法の一例は、たとえば次の通りである。Dihydropyridine 1m form (A) using compound (1)
An example of the manufacturing method is as follows.
ジヒドロピリジン誘導体は本発明化合物(りと残余成分
とを自体公知の手段で反応させること、特に脱水閉環反
応に付すことにより製造することができる。たとえば、
次のようにして製造される。The dihydropyridine derivative can be produced by reacting the compound of the present invention with the remaining components by a method known per se, particularly by subjecting it to a dehydration ring closure reaction. For example,
It is manufactured as follows.
(X)
R3COCHICOO−A−■−I3 (13)−→
ジヒドロピリジン誘4体(A)
(式中、R’ 、R” 、Rり、R’ 、R’ 、X、
AおよびBは前記定義と同意義)
化合物(L3) 、化合物(IX)および化合物(X)
の反応は通常約20℃〜160℃、好ましくは約30℃
〜130℃で行われ、使用する溶媒としては反応に不活
性なものであればいかなるものでもよく、メタノール、
エタノール、プロパツール、イソプロパツール、ブタノ
ール% 5ec−ブタノールなどのアルカノール類、エ
チルエーテル、ジオキサン、テトラヒドロフラン、エチ
レングリコールモノメチルエーテル、エチレングリコー
ルジメチルエーテルなどのエーテル類、酢酸、ピリジン
、たとえばN、N−ジメチルホルムアミド、ジメチルス
ルホキシド、アセトニトリルなどが好適なものとして挙
げられる。化合物(1−3) 、化合物(IX)および
化合物(X)の使用量は、3者のうちいずれかの化合物
1モルに対し、他の2つの化合物を・それぞれ1−1.
5モル用いることにより行われる。(X) R3COCHICOO-A-■-I3 (13)-→
Dihydropyridine derivative (A) (wherein R', R", R, R', R', X,
A and B have the same meanings as defined above) Compound (L3), Compound (IX) and Compound (X)
The reaction is usually carried out at about 20°C to 160°C, preferably about 30°C.
The reaction is carried out at ~130°C, and any solvent can be used as long as it is inert to the reaction, including methanol,
Ethanol, propatool, isoproptool, butanol% 5ec-Alkanols such as butanol, ethers such as ethyl ether, dioxane, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol dimethyl ether, acetic acid, pyridine, such as N,N-dimethylformamide , dimethyl sulfoxide, acetonitrile and the like are suitable. The usage amounts of Compound (1-3), Compound (IX) and Compound (X) are as follows: 1 mole of one of the three compounds to 1 mole of each of the other two compounds; 1-1.
This is done by using 5 mol.
当該反応が完結するまで通常1〜30時間を要する。It usually takes 1 to 30 hours until the reaction is completed.
以下、実施例を以て本発明をさらに詳しく説明するが、
これらの実施例によって本発明を限定するものではない
。Hereinafter, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited to these Examples.
実施例1
200−の三ロフラスコに2−(p−ジメチルアミノフ
ェニル)エタノール(3,131g、 18.9mwo
l)を入れ、中央に空冷管、一方に温度計、他方にセプ
タムラバーを装着した。フラスコ中にテトラヒドロフラ
ン(T)IF)(59m)を加え、内容物を熔解後、−
13〜−12℃に冷却(氷−食塩)し、ジケテン(1,
912g、 22.7m++5ol)および4−ジメチ
ルアミノピリジン(DMAP)(10mg、0.082
+wmol)を加え、同温度で30分間、室温下18時
間攪拌した0反応液を水冷し、0.1%水酸化ナトリウ
ム水溶液(75@j)を加え、酢酸エチルで抽出(90
−で4回)した、酢酸エチル層を0.1%水酸化ナトリ
ウム水溶液(75d)で洗浄し、水洗(50s7で2回
)、乾燥後、減圧留去した。残渣(5,069g)をカ
ラムクロマトグラフィー〔シリカゲル、酢酸エチル−n
−ヘキサン(1: 2) )により分離精製し、2−(
p−ジメチルアミノフェニル)エチル アセトアセテー
ト3.592 gを得た(収率ニア6%)。Example 1 2-(p-dimethylaminophenyl)ethanol (3,131 g, 18.9 mwo
1), an air-cooled tube in the center, a thermometer on one side, and a septum rubber on the other. Tetrahydrofuran (T)IF) (59m) was added to the flask, and after melting the contents, -
Cool to 13 to -12°C (ice-salt) and diketene (1,
912g, 22.7m++5ol) and 4-dimethylaminopyridine (DMAP) (10mg, 0.082
The reaction mixture was stirred at the same temperature for 30 minutes and then at room temperature for 18 hours. The reaction solution was cooled with water, 0.1% aqueous sodium hydroxide solution (75@j) was added, and extracted with ethyl acetate (90
The ethyl acetate layer was washed with a 0.1% aqueous sodium hydroxide solution (75d), washed with water (twice at 50s7), dried, and then evaporated under reduced pressure. The residue (5,069 g) was purified by column chromatography [silica gel, ethyl acetate-n
-hexane (1:2)) to separate and purify 2-(
3.592 g of p-dimethylaminophenyl)ethyl acetoacetate was obtained (yield near 6%).
I Rv二!’;r cm−’ : 1740(C=
OL 1710(C=O)’11−.NMRδ:
?、02.6.63 (4H,^z B * Q +
J −91(z ) +4.27 (2+1. t、
J=7Hz)、 3.38 (21+、 s)。I Rv2! ';r cm-': 1740 (C=
OL 1710 (C=O)'11-. NMRδ: ? , 02.6.63 (4H,^z B * Q +
J −91(z) +4.27 (2+1.t,
J=7Hz), 3.38 (21+, s).
2.89 (611,s)、 2.84 (211,t
、 J−782)。2.89 (611,s), 2.84 (211,t
, J-782).
2.20 (3H,s)
実施例2
+112−(−ジベンジルアミノフェニル)エタムニ止
50−の三ロフラスコに2−(p−アミノフェニル)エ
タノール(1,041g、 7.59m+5ol)を入
れ、中央にジムロート冷却器、左右にセプタムラバーを
装着した。フラスコ中にN、N−ジメチルホルムアミド
(DMF)(8,6mj)を加え、内容物を溶解後、炭
酸カリウム(4,195g、30.4mmol)及びベ
ンジルプロミド(2,985g、 17.5meal)
を加え、室温下2.5時間攪拌した0反応液に水(40
−)を加え、ジエチルエーテルで抽出(40atZで4
回)した、エーテル層を水洗(25dで1回)、乾燥後
、減圧留去し、残渣(3,042g)をカラムクロマト
グラフィー〔シリカゲル、クロロホルム−メタノール(
981)3により分離精製し、2−(p−ジベンジルア
ミノフェニル)エタノール2゜275gを得た(収率:
94%)。2.20 (3H, s) Example 2 +112-(-dibenzylaminophenyl)etham 2-(p-aminophenyl)ethanol (1,041 g, 7.59 m + 5 ol) was placed in a 50-mm three-neck flask, and the center A Zimroth cooler was installed and septum rubber was installed on the left and right sides. Add N,N-dimethylformamide (DMF) (8.6 mj) into the flask, dissolve the contents, and then add potassium carbonate (4,195 g, 30.4 mmol) and benzyl bromide (2,985 g, 17.5 meal).
was added and stirred at room temperature for 2.5 hours, and then water (40
-) and extracted with diethyl ether (40atZ
The ether layer was washed with water (once at 25 d), dried and evaporated under reduced pressure, and the residue (3,042 g) was subjected to column chromatography [silica gel, chloroform-methanol (
981) 3 to obtain 275 g of 2-(p-dibenzylaminophenyl)ethanol (yield:
94%).
IRν:::Lcm−’ : 3350(OH)’I
I−NMRδニ
ア、18 (IQII、 s)。IRν:::Lcm-': 3350(OH)'I
I-NMRδ near, 18 (IQII, s).
6.92.6.62 (411,AIBvQ、J=8.
5112)。6.92.6.62 (411, AIBvQ, J=8.
5112).
4.56 (41(、s)、 3.71 (2H,t、
J−6tlz)。4.56 (41(,s), 3.71 (2H,t,
J-6tlz).
2.69 (211,t、 J=6Hz)、 1.48
(18,5)200−の三ロフラスコに2−(p−ジ
ベンジルアミノフェニル)エタノール(7,020g、
22.1mmo 1 )を入れ、中央に空冷管、一方
に温度計、他方にセプタムラバーを装着した。フラスコ
中にジエチルエーテル(68a7)を加え、内容物を溶
解後、−13〜−12℃に冷却(氷−食塩)し、ジケテ
ン(2,113g、 25.1wmol)およびDMA
P (9w、0.074 +mmol)を加え、同温度
で40分間、室温下16.5時間攪拌した。反応液を、
氷冷した0、1%水酸化ナトリウム水溶液(90d)(
300−の三角フラスコ使用)中に加え、洗浄後、ジエ
チルエーテル層を分液した。水層をエーテル抽出(11
0mZで3回)し、エーテル層を合わせ、0.1%水酸
化ナトリウム水溶液で洗浄(9〇−で2回)し、水洗(
50mlで2回)、乾燥後、減圧留去した。残渣(7,
972g)をカラムクロマトグラフィー〔シリカゲル、
酢酸エチル−〇−へキサン(1: 3) )により分離
精製し、2−(p−ジベンジルアミノフェニル)エチル
アセトアセテ−)7.266gを得た(収率:82%
)。2.69 (211,t, J=6Hz), 1.48
(18,5) 2-(p-dibenzylaminophenyl)ethanol (7,020 g,
22.1 mmo 1 ) was placed in the tube, and an air-cooled tube was placed in the center, a thermometer was attached to one end, and a septum rubber was attached to the other end. Add diethyl ether (68a7) to the flask, dissolve the contents, and cool to -13 to -12°C (ice-salt) to dissolve diketene (2,113 g, 25.1 wmol) and DMA.
P (9w, 0.074 + mmol) was added, and the mixture was stirred at the same temperature for 40 minutes and at room temperature for 16.5 hours. The reaction solution,
Ice-cold 0.1% aqueous sodium hydroxide solution (90d) (
After washing, the diethyl ether layer was separated. Extract the aqueous layer with ether (11
The ether layers were combined, washed with 0.1% aqueous sodium hydroxide solution (twice at 90°C), and washed with water (
After drying, the mixture was distilled off under reduced pressure. Residue (7,
972g) was subjected to column chromatography [silica gel,
Separation and purification using ethyl acetate-〇-hexane (1:3) gave 7.266 g of 2-(p-dibenzylaminophenyl)ethyl acetoacetate (yield: 82%).
).
I Rj’::Pcl1−’ : 1740(C−0
)、 1720(C−0)’H−NMRδニ
ア、19 (1011,s)、 7.1−6.8
(211)。I Rj'::Pcl1-': 1740 (C-0
), 1720(C-0)'H-NMRδ Near, 19 (1011,s), 7.1-6.8
(211).
6.75−6.5 (211)、 4.57 (
411,s)。6.75-6.5 (211), 4.57 (
411, s).
4’、25 (211,t、 J・611z)、
3.36 (211,s)。4', 25 (211,t, J・611z),
3.36 (211, s).
2.81 (211,t、 J=611z)、
2.15 (311,s)実施例3
(1)に」」二」≧(し乙ムム五三火とλノノール20
0 mlのナスフラスコに2−(p−アミノフェニル)
エタノール(10,153g、 74.0m5ol)お
よびビス(2−クロロエチル)アミン塩酸塩(6,60
5g、 37.0+m5ol)を入れ、n−ブタノール
(66aZ)を加え、ジムロート冷却器を装着し、23
.5時間加熱還流した0反応液を室温付近まで冷却後、
500m/のビーカーに入れた水(218117)中に
加えた。水冷下、15%水酸化ナトリウム水溶液を加え
、pHlo〜11とした後、クロロホルムで抽出(30
0−で5回)した、クロロホルム層を水洗(150+a
/で2回)し、乾燥後、減圧留去し、残渣(13,48
5g)をカラムクロマトグラフィー(シリカゲル、クロ
ロホルム−メタノール(1: 1) )により分離精製
し、標記のピペラジン体5.996 gを得たく収率ニ
ア9%)。2.81 (211,t, J=611z),
2.15 (311, s) Example 3 (1) ``2'' ≧ (Shiotsumumu Gosanka and λnonol 20
2-(p-aminophenyl) in a 0 ml eggplant flask
Ethanol (10,153g, 74.0m5ol) and bis(2-chloroethyl)amine hydrochloride (6,60ml)
5g, 37.0+m5ol), added n-butanol (66aZ), equipped with a Dimroth cooler,
.. After cooling the 0 reaction solution heated under reflux for 5 hours to around room temperature,
It was added to water (218117) in a 500 m/m beaker. Under water cooling, 15% aqueous sodium hydroxide solution was added to adjust the pH to ~11, followed by extraction with chloroform (30%
The chloroform layer was washed with water (150+a
/ twice), dried, and then evaporated under reduced pressure to obtain a residue (13,48
5 g) was separated and purified by column chromatography (silica gel, chloroform-methanol (1:1)) to obtain 5.996 g of the title piperazine compound (yield near 9%).
I RuHHCm−’ = 3300(OH)重H−N
MRδニ
ア、15−6.95 (2H)、 6.95−6.7
(2H)。I RuHHCm-' = 3300 (OH) heavy H-N
MRδ near, 15-6.95 (2H), 6.95-6.7
(2H).
3.77 (2)1. t、 J=6Hz)、 3.2
−2.8 (8H)。3.77 (2)1. t, J=6Hz), 3.2
-2.8 (8H).
2.75 (211,t、 J=6Hz)、 2.10
(2H,5)100−の三ロフラスコに(1)の生成
物(ピペラジン体)(5,996g、29.1 mmo
l)を入れ、中央にジムロート冷却器、左右にセプタム
ラバーを装着した。フラスコ中にDMF(33m)を加
え、内容物を溶解後、炭酸カリウム(8,034g、
5B、1曽曽o1) 及びプロモジフエニlレメタン(
7,543g、30、5wmol)を加え、室温下2時
間攪拌した0反応液を、200−の三角フラスコに入れ
た水(8〇−)中に加え、ジエチルエーテルで抽出(1
00−で4回)した、エーテル層を水洗(40−で2回
)、乾燥後、減圧留去し、残渣(10,616g )を
カラムクロマトグラフィー〔シリカゲル、酢酸エチル−
n−ヘキサン(1: 1) )により分離精製し、2−
(p−(4−ベンズヒドリルピペラジノ)フェニル〕
エタノール6.188 gを得たて収率57%)。2.75 (211,t, J=6Hz), 2.10
(2H,5) The product of (1) (piperazine compound) (5,996 g, 29.1 mmo
1), a Dimroth cooler was installed in the center, and septum rubbers were installed on the left and right sides. Add DMF (33m) to the flask and dissolve the contents, then add potassium carbonate (8,034g,
5B, 1 soso o1) and promodiphenyl remethane (
7,543g, 30.5wmol) was added and stirred at room temperature for 2 hours.The reaction solution was added to water (80-) placed in a 200- Erlenmeyer flask, and extracted with diethyl ether (1
The ether layer was washed with water (twice at 40°C), dried and evaporated under reduced pressure, and the residue (10,616g) was purified by column chromatography [silica gel, ethyl acetate].
Separated and purified using n-hexane (1:1)), 2-
(p-(4-benzhydrylpiperazino)phenyl)
6.188 g of ethanol was obtained (fresh yield 57%).
I Ry:::”cm −’ : 3600(
OR)’H−N M Rδニ
ア、55−6.9 (1211)、 6.9−6.55
(2H)。I Ry:::”cm-’: 3600(
OR)'H-N M Rδ near, 55-6.9 (1211), 6.9-6.55
(2H).
4.23 (IH,s)、 3.72 (2H,t、
J=611z)。4.23 (IH, s), 3.72 (2H, t,
J=611z).
3.3−2.95 (4+1)、 2.95−2.35
(611)。3.3-2.95 (4+1), 2.95-2.35
(611).
1.71 (IH,5)
(2)の生成物(ベンズヒドリルピペラジン体) (5
,970g−16,0mmol)を200−の三ロフラ
スコに入れ、中央に空冷管、一方に温度計、他方にセプ
タムラバーを装着した。フラスコ中にジエチルエーテル
(50d)を加え、内容物を溶解後、−13〜−12℃
に冷却(氷−食塩)し、ジケテン(1,531g−18
,2mmol)およびDMAP (7at、 0.05
7 nnol)を加え、同温度で30分間、室温下17
.5時間撹拌した0反応液を氷冷し、0.1%水酸化ナ
トリウム水溶>& (65@l)を加え、洗浄後、ジエ
チルエーテル層を分液した。水層をエーテル抽出(12
0m7で3回)し、エーテル層を合わせ、0.1%水酸
化ナトリウム水溶液で洗浄(65−で2回)し、水洗(
50s7で2回)、乾燥後、減圧留去し、2− (p
−(4−ベンズヒドリルピペラジノ)フェニル〕エチル
アセトアセテート7、364 gを定量的に得た。1.71 (IH, 5) Product of (2) (benzhydrylpiperazine) (5
, 970 g - 16.0 mmol) was placed in a 200-meter three-hole flask, and an air-cooled tube was placed in the center, a thermometer was attached to one end, and a septum rubber was attached to the other end. Add diethyl ether (50d) to the flask, dissolve the contents, and then heat to -13 to -12°C.
(ice-salt) and diketene (1,531g-18
, 2 mmol) and DMAP (7at, 0.05
7 nnol) and incubated at the same temperature for 30 minutes at room temperature.
.. The reaction solution stirred for 5 hours was ice-cooled, 0.1% aqueous sodium hydroxide (65@l) was added, and after washing, the diethyl ether layer was separated. Extract the aqueous layer with ether (12
The ether layers were combined and washed with 0.1% sodium hydroxide aqueous solution (twice at 65-cm), and then washed with water (
2 times at 50 s7), and after drying, distilled off under reduced pressure to obtain 2- (p
-(4-benzhydrylpiperazino)phenyl]ethyl acetoacetate 7.364 g was quantitatively obtained.
I RvQ:j’cm−’ : 1740(C=O)
、 1720(C=0)II−NMRδニ
ア、6−6.9 (12H)、 6.9−6.65 (
211)。I RvQ:j'cm-': 1740 (C=O)
, 1720 (C=0) II-NMR δ near, 6-6.9 (12H), 6.9-6.65 (
211).
4.29 (21,t、 J=6.5H2)、 4.2
4 (Ill、 s)+3.39 (211,s)、
3.35−3.0 (411)。4.29 (21,t, J=6.5H2), 4.2
4 (Ill, s) + 3.39 (211, s),
3.35-3.0 (411).
2.85 (28,t、 J=6.5)1z)、 2.
7−2.4 (4)1)。2.85 (28,t, J=6.5)1z), 2.
7-2.4 (4)1).
2.18 (3H,s)
実施例4
2−(p−アミノフェニル)エタノールの代わりに3−
(p−アミノフェニル)プロパツールを用いる以外は全
て実施例3(1821に準じて行い、目的化合物を得た
。2.18 (3H,s) Example 4 3-instead of 2-(p-aminophenyl)ethanol
The procedure of Example 3 (1821) was followed except that (p-aminophenyl)propanol was used to obtain the target compound.
目的化合物の性状 無色油状物
I Rv:a:”cm−’ : 3600(OH)’
H−NMRδニ
ア、5〜7.05 (Loll)、 7.05〜6.8
5 (211)。Properties of target compound Colorless oil I Rv:a:"cm-': 3600(OH)'
H-NMR δ near, 5-7.05 (Loll), 7.05-6.8
5 (211).
6.85〜6.6 (211)、 4.19 (IH,
s)。6.85-6.6 (211), 4.19 (IH,
s).
3.55 (21,t、 J=611z)、 3.25
〜2.’15 (411)。3.55 (21,t, J=611z), 3.25
~2. '15 (411).
2.75〜2.35 (6H)、 2.05〜1.45
(2+1)11)の生成物を用いる以外は実施例3(
3)に準じて行い目的化合物を得た。2.75-2.35 (6H), 2.05-1.45
Example 3 (except using the product of (2+1)11)
The desired compound was obtained according to 3).
IRν、ニー′″cm−’ : 1740(C−0)
、 1720(C=O)’H−N M Rδニ
ア、6〜7.1 (1011)、 7.1〜6.9 (
2+1)。IRν, knee'''cm-': 1740 (C-0)
, 1720(C=O)'H-N M Rδ near, 6-7.1 (1011), 7.1-6.9 (
2+1).
6.9〜6.65 (2H)、 4.27 (IH,s
)。6.9-6.65 (2H), 4.27 (IH,s
).
4.12 (2H,t、 J−6Hz)、 3.42
(2H,s)。4.12 (2H, t, J-6Hz), 3.42
(2H, s).
3.35〜3.0 (411)、 2.8〜2.4 (
611)。3.35~3.0 (411), 2.8~2.4 (
611).
2.26 (3H,s)、 2.INl、6 (2
H)手続(市正吉(自発)
昭和62年7月13日2.26 (3H,s), 2. INl, 6 (2
H) Procedures (Ichi Masakichi (voluntary) July 13, 1986
Claims (1)
コキシアルキルを示す)で表わされる基を、Aはアルキ
レンを、Bは−N(R^6)_2または▲数式、化学式
、表等があります▼ (R^6およびR^7はそれぞれ水素原子、アルキル、
シクロアルキル、アラルキル、アリールまたはピリジル
を、Arはアリールまたはピリジルを、nは0〜2の整
数をそれぞれ示す)で表わされる基を示す〕で表わされ
る化合物。[Claims] General formula ▲ Numerical formulas, chemical formulas, tables, etc. or alkoxyalkyl), A is alkylene, B is -N(R^6)_2 or ▲Numerical formula, chemical formula, table, etc.▼ (R^6 and R^7 are each a hydrogen atom , alkyl,
a group represented by cycloalkyl, aralkyl, aryl or pyridyl, Ar represents aryl or pyridyl, and n represents an integer of 0 to 2, respectively.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62115590A JPH0822857B2 (en) | 1987-05-12 | 1987-05-12 | Benzene compound |
US07/087,513 US4886819A (en) | 1986-08-27 | 1987-08-20 | Dihydropyridine derivatives and pharmaceutical composition thereof |
CA000545173A CA1323876C (en) | 1986-08-27 | 1987-08-24 | Dihydropyridine derivatives and pharmaceutical composition thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62115590A JPH0822857B2 (en) | 1987-05-12 | 1987-05-12 | Benzene compound |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61200849 Division | 1986-08-27 | 1986-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6399042A true JPS6399042A (en) | 1988-04-30 |
JPH0822857B2 JPH0822857B2 (en) | 1996-03-06 |
Family
ID=14666369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62115590A Expired - Lifetime JPH0822857B2 (en) | 1986-08-27 | 1987-05-12 | Benzene compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0822857B2 (en) |
-
1987
- 1987-05-12 JP JP62115590A patent/JPH0822857B2/en not_active Expired - Lifetime
Non-Patent Citations (3)
Title |
---|
BEILSTEINS HANDBUCH DER ORGANISCHEN CHEMIE=1930 * |
BEILSTEINS HANDBUCH DER ORGANISCHEN CHEMIE=1950 * |
BEILSTEINS HANDBUCH DER ORGANISCHEN CHEMIE=1985 * |
Also Published As
Publication number | Publication date |
---|---|
JPH0822857B2 (en) | 1996-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6061158B2 (en) | Synthesis intermediate of 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use | |
KR20180005248A (en) | Synthesis of heterocyclic compounds | |
CN104447686B (en) | Polysubstituted 2-pyrroles's pyridine derivate and preparation method thereof | |
WO2021190604A1 (en) | Preparation of cyclosporin derivatives | |
AU2002250962B2 (en) | Process for the preparation of mesylates of piperazine derivatives | |
JP2012188414A (en) | Improvement of method for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, intermediate of etoricoxib | |
AU2002250962A1 (en) | Process for the preparation of mesylates of piperazine derivatives | |
JP6705458B2 (en) | Method for producing triazole compound | |
EP3478684B1 (en) | New processes for the preparation of vemurafenib | |
JPS6399042A (en) | Benzene based compound | |
JP6407645B2 (en) | Perfluoroalkylation of aromatic compounds | |
HU208533B (en) | Process for selective etherification of ascorbinic acid derivatives | |
US4474953A (en) | Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones | |
JPH04235976A (en) | Production of aralkylaminopyrimidine compounds | |
EP2888250B1 (en) | Process for the synthesis of substituted gamma lactams | |
US6252082B1 (en) | Pyridone derivatives, their preparation and their use as synthesis intermediates | |
KR101580821B1 (en) | Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide | |
JP4361290B2 (en) | Esculetin derivative, method for producing the same, and method for purifying esculetin | |
JP2002220371A (en) | Method for producing n-vinyl carbazoles | |
JP4241975B2 (en) | Method for producing 2-sulfonylpyridine derivative | |
JPH04270272A (en) | Production of aminoalkylmorpholine derivative | |
KR790001654B1 (en) | Process for the preparation of s-triazolo(3,4-b)benzothiazoles | |
CN113214224A (en) | Preparation method of polysubstituted 3-methylene isoindolinone derivative | |
JPS58167574A (en) | Dicarbamates | |
US20060217554A1 (en) | Processes for producing pyrazoloacridone derivative and synthetic intermediate thereof |